Qsd Formulations Private Limited, a active private limited company, was established on 13 December 2016 in Sonepat, Haryana, India. Engaging in ayurvedic products & services within the hospital and medical care sector, it holds CIN: U47219HR2016PTC066654. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 10 professional, Its leadership includes Ruchika Monga (Director), Girnish Kheterpal (Director), Rajiv Monga (Director). Past directors included Ravi Kumar Verma. It holds ₹2.44 Cr open charges and ₹1.07 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1256 Sector-38, Ph-1 Hsiidc Rai Sonepat, Sonepat, Haryana, 131012.
U47219HR2016PTC066654
066654
13 December 2016
₹5.00 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Qsd Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ruchika Monga | Director | 12 Dec 2019 | Current |
| Girnish Kheterpal | Director | 13 Dec 2016 | Current |
| Rajiv Monga | Director | 09 May 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 May 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Qsd Formulations Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.01% increase. The company also saw a substantial fall in profitability, with a 81.26% decrease in profit. The company's net worth moved up by a moderate rise of 4.68%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Qsd Formulations had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹24,376,000.00
₹10,700,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Nov 2024 | Others | ₹3.20 M | Open |
| 21 Sep 2020 | Others | ₹3.53 M | Open |
| 12 Mar 2020 | Others | ₹1.77 Cr | Open |
| 23 Jan 2023 | Hdfc Bank Limited | ₹1.07 Cr | Satisfied |
Explore comprehensive loan charge details -
Qsd Formulations has a workforce of 10 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Qsd Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qsd Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 3.20 M with Charge ID 101032606 was registered on 23 Nov 2024. was recorded as a recent event.
A charge registered on 23 Jan 2023 via Charge ID 100705099 with Hdfc Bank Limited was fully satisfied on 06 Nov 2024. was recorded as a recent event.
Qsd Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Qsd Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Progress on Rajiv Monga was appointed as a Director was appointed as a Director on 09 May 2023 & has been associated with this company since 2 years 6 months . was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 10.70 M with Charge ID 100705099 was registered on 23 Jan 2023. was documented.
The CIN of Qsd Formulations Private Limited is U47219HR2016PTC066654.
Qsd Formulations Private Limited is headquartered at 1256 Sector-38, Ph-1 Hsiidc Rai Sonepat, Sonepat, Haryana, 131012.
Qsd Formulations Private Limited was incorporated on 13 December 2016.
The current directors of Qsd Formulations Private Limited are
The primary industry of Qsd Formulations Private Limited is Hospital And Medical Care.
Qsd Formulations Private Limited is unlisted.
The authorized capital of Qsd Formulations Private Limited is ₹5.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Qsd Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX